Dehydroabietic acid

CAS No. 1740-19-8

Dehydroabietic acid( —— )

Catalog No. M18122 CAS No. 1740-19-8

Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 50 In Stock
10MG 87 In Stock
25MG 165 In Stock
50MG 248 In Stock
100MG 357 In Stock
500MG 845 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dehydroabietic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.
  • Description
    Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor. DAA is a useful food-derived compound for treating obesity-related diseases, by decreasing plasma glucose, insulin levels, plasma triglyceride (TG) , and hepatic TG levels. DAA derivatives displays anti-secretory and anti-pepsin effect in animal models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EBV
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    1740-19-8
  • Formula Weight
    300.44
  • Molecular Formula
    C20H28O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (332.85 mM)
  • SMILES
    CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)C(=O)O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Epertinib hydrochlor...

    Epertinib hydrochloride shows potent antitumor activity.?

  • PF-06747775

    A potent, selective, irreversible EGFR mutants with IC50 of 12, 3, 4 and 5 nM for EGFR L858R-T790M, Del-T790M, L858R, and EGFR Del, respectively.

  • EGFR-IN-8

    EGFR-IN-8 can be a promising candidate for further development to target EGFR TKI-resistant NSCLC. EGFR-IN-8 is a dual EGFR and c-Met inhibitor.